Alle Storys
Keine Story von Intercell AG mehr verpassen.

Intercell AG

euro adhoc: Intercell AG
Financing, Stock Offerings / Over-allotment option exercised

Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.
Goldman Sachs International today exercised the over-allotment option
granted in connection with Intercell AG’s initial public offering. 
The over-allotment shares comprise 277,935 shares provided by
existing shareholders and 989,132 new shares to be issued by the
Company in a capital increase.  Following the exercise of the
over-allotment option, the aggregate proceeds to the Company are EUR
52.2 million.  The total outstanding share capital of Intercell AG
following completion of its IPO amounts to 33,010,205 shares.
The information contained herein is not for publication or
distribution in the United States of America. This press release is
not an offer of securities for sale in the United States. Securities
may not be offered or sold in the United States absent registration
or an exemption from registration under the U.S. Securities Act of
1933, as amended. Any public offering of securities to be made in the
United States will be made by means of a prospectus that may be
obtained from Intercell AG and that will contain detailed information
about the company and management, as well as financial statements.
This document is for distribution in the U.K. only to (i) persons who
have professional experience in matters relating to investments
falling within article 19(5) of the Financial Services and Markets
Act 2000 (Financial Promotion) Order 2001 (the "Order") or (ii) high
net worth entities falling within article 49(2)(a) to (e) of the
Order (all such persons being together referred to as "relevant
persons"). This document is directed only at relevant persons. Other
persons should not act or rely on this document or any of its
contents. This document is confidential and is being supplied to you
solely for your information and may not be reproduced, redistributed
or passed on to any other person or published, in whole or in part,
for any other purpose.
end of announcement                    euro adhoc 18.03.2005 08:37:13 

Further inquiry note:

Intercell AG
Mag. Katharina Wieser
Head of Corporate Communications
Tel. +43 1 20620-303

Branche: Biotechnology
ISIN: AT0000612601
Börsen: Wiener Börse AG / official market

Weitere Storys: Intercell AG
Weitere Storys: Intercell AG